Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Prevalence and determinants of gestational diabetes mellitus at a tertiary health facility in Lagos, Nigeria
Recent Trends in GLP-1 Use and Spending in Medicare Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, new data from the Centers for Medicare & Medicaid Services (CMS) shows that use and spending for these drugs under Medicare has grown substantially in recent years, reflecting their demonstrated effectiveness at treating type 2 diabetes and other conditions
Experimental and Molecular Medicine
However, there are no published clinical trials of the drug among people without these disorders
US$ 22.35
US$ 23.90
US$ 26.39
US$ 24.38
US$ 22.93
